Be in the know. 27 key reads for Tuesday…

  1. Wells Fargo Stock: ‘Not So Much a Question of If but When the Stock Will Work’ (Barron’s)
  2. JPMorgan’s Jamie Dimon Tells Analysts Reserve Releases Could Come (Barron’s)
  3. Scientists discover antibody that ‘neutralizes’ virus that causes coronavirus (New York Post)
  4. The Fed Meeting Starts Today. Here’s What Markets Are Expecting. (Barron’s)
  5. Global Stocks See Boost From China Retail Surprise, Wall Street Strength (Barron’s)
  6. House to Introduce Bipartisan Stimulus Bill (Barron’s)
  7. Time For Another Dirty Dozen Beaten Up Stocks That Can Pop As The Economy Improves (Barron’s)
  8. Barron’s Daily: Steve Cohen Finally Buys the Mets. You Can Buy the Braves. (Barron’s)
  9. Confused About Oracle’s Deal With TikTok? What It Could Mean. (Barron’s)
  10. China’s economic recovery gained speed in August (MarketWatch)
  11. Snowflake’s Big IPO Is Coming This Week as New Issue Market Heats Up (Barron’s)
  12. ‘There Is Little Money to Be Made Almost Anywhere in The World,’ Bill Gross Says (Barron’s)
  13. Amazon to Hire 100,000 in U.S. and Canada (Wall Street Journal)
  14. New Insights Into Dreams and What They Say About Us (Wall Street Journal)
  15. SoftBank’s Masayoshi Son Has Cash Burning a Hole in His Pocket (Wall Street Journal)
  16. Billionaire Steven Cohen Reaches Deal to Buy New York Mets (Wall Street Journal)
  17. A Spoonful of Suga Could Sweeten Japan’s Post-Abe Economy (Wall Street Journal)
  18. Daniel Boulud’s Next Restaurant Nods to a New York Classic (New York Times)
  19. New York Manufacturing Expands at Second-Fastest Pace Since 2018 (Bloomberg)
  20. Citigroup to Resume Job Cuts After Pausing for Pandemic (Bloomberg)
  21. Big Investors Are Dying to Know What Amateur Traders Are Doing (Bloomberg)
  22. Opinion: Here’s the big secret of how the richest Americans made their wealth (MarketWatch)
  23. Stock market’s 7% pullback? Get ready for more, as a 2009-style ‘stair-step’ rally continues, says Wall Street bull (MarketWatch)
  24. Trump Says He Wants a 4-Hour Debate Moderated by Joe Rogan (Bloomberg)
  25. Annie Duke – How to Decide (EP.156) CapitalAllocatorsPodcast)
  26. Warren Buffett names Kathryn Farmer to be 1st female CEO of major U.S. railroad (Fox Business)
  27. Gilead Analysts Dissect Immunomedics Deal: ‘Pricier But Bold Move Into Oncology’ (Benzinga)

Be in the know. 10 key reads for Monday…

  1. Wells Fargo upgraded to Outperform from Peer Perform at Wolfe Research (TheFly)
  2. Oracle Wins TikTok Bid, Beating Out Microsoft and Walmart (Barron’s)
  3. Boeing execs defend safety decisions on 737 MAX development (FoxBusiness)
  4. Investors in Japan should get set for a ‘Suga high’ (Financial Times)
  5. Gilead Sciences Agrees $21 Billion Takeover Of Cancer Drug Specialist Immunomedics (TheStreet)
  6. Why Fed Officials Are Begging for More Stimulus From Lawmakers (Wall Street Journal)
  7. Stocks Rallied, and Many Missed Out (Wall Street Journal)
  8. Here’s why markets shouldn’t overlook the Fed meeting next Wednesday (MarketWatch)
  9. Pfizer CEO: Coronavirus vaccine could be distributed in U.S. by end of year (MarketWatch)
  10. Nvidia Is Buying Arm Holdings in Largest Ever Chip Deal (Barron’s)

Be in the know. 14 Key reads for Sunday…

  1. Warren Buffett’s $570 million bet on Snowflake shows he completely trusts his deputies, investor Jake Taylor says (Business Insider)
  2. Oxford and AstraZeneca resume coronavirus vaccine trial (Financial Times)
  3. We Buy A Junk Bond (NPR Planet Money)
  4. 10 Scientific Laws and Theories You Really Should Know (How Stuff Works)
  5. A Primer on Algorithms and Bias (Farnam Street)
  6. The Fed Will Trigger Hot-Running Inflation, Druckenmiller Warns (CIO)
  7. Where to Find Bargains in Oil Stocks Now (Barron’s)
  8. After Abe, more Abenomics — for better or worse (Pensions&Investments)
  9. Goldman’s 10 Reasons That the Bull Market Will Resume (CIO)
  10. Pfizer proposes expansion of late-stage coronavirus vaccine trial (CNBC)
  11. Gilead is getting closer to a deal to buy Immunomedics for more than $20 billion (CNBC)
  12. Japan’s Suga says no limit to bonds government can issue (Reuters)
  13. Southern California Research Institute Receives FDA Greenlight for Ivermectin Clinical Trial (TrialSiteNews)
  14. Small Caps Emerge Relatively Unscathed in Megatech Bludgeoning (Bloomberg)